121 related articles for article (PubMed ID: 38303299)
1. [Intraperitoneal Transfer of miR-29b Containing Exosome Suppresses the Development of Peritoneal Metastases from Gastric Cancer].
Kimura Y; Ohzawa H; Kaneko Y; Miyato H; Kurashina K; Saito S; Yamaguchi H; Hosoya Y; Sata N; Kitayama J
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1435-1437. PubMed ID: 38303299
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal transfer of microRNA-29b-containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer.
Kimura Y; Ohzawa H; Miyato H; Kaneko Y; Kuchimaru T; Takahashi R; Yamaguchi H; Kurashina K; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Cancer Sci; 2023 Jul; 114(7):2939-2950. PubMed ID: 36939028
[TBL] [Abstract][Full Text] [Related]
3. MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial-mesenchymal transition (MMT) of human peritoneal mesothelial cells.
Kimura Y; Ohzawa H; Miyato H; Kaneko Y; Saito A; Takahashi K; Tojo M; Yamaguchi H; Kurashina K; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Sci Rep; 2022 Jan; 12(1):205. PubMed ID: 34997082
[TBL] [Abstract][Full Text] [Related]
4. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer.
Ohzawa H; Kimura Y; Saito A; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Ann Surg Oncol; 2020 Dec; 27(13):5057-5064. PubMed ID: 32804324
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of cancer-associated fibroblast exosome-derived miR-29b-1-5p restrains vasculogenic mimicry and apoptosis while accelerating migration and invasion of gastric cancer cells via immunoglobulin domain-containing 1/zonula occluden-1 axis.
Wu C; Li D; Cheng X; Gu H; Qian Y; Feng L
Cell Cycle; 2023 Sep; 22(17):1807-1826. PubMed ID: 37587724
[No Abstract] [Full Text] [Related]
6. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7.
Zhu M; Zhang N; He S; Lu X
Cell Cycle; 2020 May; 19(10):1200-1221. PubMed ID: 32267797
[TBL] [Abstract][Full Text] [Related]
8. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
[TBL] [Abstract][Full Text] [Related]
9. Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells.
Arita T; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Ogino S; Fujita Y; Hiramoto H; Hamada J; Shoda K; Kosuga T; Fujiwara H; Okamoto K; Otsuji E
Oncotarget; 2016 Aug; 7(35):56855-56863. PubMed ID: 27487135
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis.
Makinoya M; Miyatani K; Matsumi Y; Sakano Y; Shimizu S; Shishido Y; Hanaki T; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Nakayama Y; Osaki M; Okada F; Fujiwara Y
Sci Rep; 2024 May; 14(1):10075. PubMed ID: 38698201
[TBL] [Abstract][Full Text] [Related]
11. Decreased exosome-delivered miR-486-5p is responsible for the peritoneal metastasis of gastric cancer cells by promoting EMT progress.
Lin XM; Wang ZJ; Lin YX; Chen H
World J Surg Oncol; 2021 Oct; 19(1):312. PubMed ID: 34686196
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cell-derived exosome miR-29b-3p alleviates UV irradiation-induced photoaging in skin fibroblast.
Yan T; Huang L; Yan Y; Zhong Y; Xie H; Wang X
Photodermatol Photoimmunol Photomed; 2023 May; 39(3):235-245. PubMed ID: 35950642
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
[TBL] [Abstract][Full Text] [Related]
14. Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer.
Kumagai Y; Futoh Y; Miyato H; Ohzawa H; Yamaguchi H; Saito S; Kurashina K; Hosoya Y; Lefor AK; Sata N; Kitayama J
In Vivo; 2022; 36(3):1126-1135. PubMed ID: 35478147
[TBL] [Abstract][Full Text] [Related]
15. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway.
Hou K; Li G; Zhao J; Xu B; Zhang Y; Yu J; Xu K
J Neuroinflammation; 2020 Feb; 17(1):46. PubMed ID: 32014002
[TBL] [Abstract][Full Text] [Related]
16. PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis.
Wu P; Wang J; Mao X; Xu H; Zhu Z
Histol Histopathol; 2021 Apr; 36(4):447-457. PubMed ID: 33442866
[TBL] [Abstract][Full Text] [Related]
17. Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer.
Ohzawa H; Kumagai Y; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Kawarai Lefor A; Sata N; Kitayama J
Ann Gastroenterol Surg; 2020 Jan; 4(1):84-93. PubMed ID: 32021962
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.
Wang XL; Chen XM; Fang JP; Yang CQ
Acta Pharmacol Sin; 2012 Apr; 33(4):513-22. PubMed ID: 22407230
[TBL] [Abstract][Full Text] [Related]
19. Integration of exosomal miR-106a and mesothelial cells facilitates gastric cancer peritoneal dissemination.
Zhu M; Zhang N; Ma J; He S
Cell Signal; 2022 Mar; 91():110230. PubMed ID: 34958869
[TBL] [Abstract][Full Text] [Related]
20. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
